Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cortlandt Manor, NY
NPI
1801054697
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1985 Crompond Rd
Cortlandt Manor, NY, 10567
Phone (914) 930-2007
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,473 services
Medicare patients, 2024
562
Average age 73
Drug cost, 2024
$4.3M
6,971 prescriptions
Company payments, 2025
$4,022
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Himani Chandra was code 99214 (office e&m - established), 690 times for 455 patients. In total Himani Chandra billed 1,473 services in 12 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 690 | 455 | $107.22 | $74K |
| 36415 Venipuncture Blood Collection | Office | 447 | 311 | $8.65 | $3,867 |
| 99204 Office E&M - New | Office | 106 | 106 | $144.57 | $15K |
| 95251 Test - Miscellaneous | Office | 94 | 61 | $30.41 | $2,859 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 70 | 70 | $14.07 | $985 |
| 99215 Office E&M - Established | Office | 26 | 25 | $173.89 | $4,521 |
| 96372 Injection Administration | Office | 15 | 12 | $14.03 | $211 |
By year: 2022 $115K for 1,506 services; 2023 $104K for 1,475 services; 2024 $104K for 1,473 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 447 | 311 | $8.65 | $3,867 |
Medicare prescription drug claims, 2024
In 2024, the drug Himani Chandra prescribed most often to Medicare patients was Ozempic (Semaglutide), with 760 prescriptions and refills. In total Himani Chandra wrote 6,971 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 760 | 1,363 | 172 | $1.3M |
| Levothyroxine Sodium Generic | 709 | 1,911 | 200 | $9,728 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 474 | 980 | 119 | $562K |
| Metformin Hcl Er Metformin Hcl | 378 | 1,071 | 135 | $4,488 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 257 | 634 | 97 | $26K |
| Jardiance Empagliflozin | 249 | 557 | 73 | $321K |
| Rosuvastatin Calcium Generic | 244 | 671 | 84 | $3,821 |
| Mounjaro Tirzepatide | 224 | 275 | 49 | $287K |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 221 | 452 | 45 | $233K |
| Atorvastatin Calcium Generic | 210 | 572 | 66 | $2,037 |
| Synthroid Levothyroxine Sodium | 204 | 512 | 47 | $9,948 |
| Trulicity Dulaglutide | 180 | 281 | 40 | $269K |
| Glimepiride Generic | 160 | 437 | 52 | $1,719 |
| Metformin Hcl Generic | 139 | 394 | 43 | $1,259 |
| Losartan Potassium Generic | 124 | 337 | 40 | $1,513 |
Brand drugs: 3,812 claims; generic drugs: 2,699 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Himani Chandra $4,022 ($4,022 in general payments such as food, travel and fees) from 19 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $3,314.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $3,314 |
| Novo Nordisk Inc NVO | 7 | $145 |
| Lilly USA, LLC LLY | 8 | $134 |
| Corcept Therapeutics CORT | 2 | $50.43 |
| Insulet Corporation PODD | 2 | $45.85 |
| Beta Bionics, Inc. BBNX | 2 | $41.83 |
| Soleno Therapeutics, Inc. SLNO | 1 | $28.48 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $28.45 |
| Madrigal Pharmaceuticals MDGL | 1 | $26.29 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $26.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.